FWI
AZN icon

Facet Wealth Inc’s AstraZeneca AZN Stock Holding History

Facet Wealth Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Buy
1,416
+203
+17% +$39.1K ﹤0.01% 272
2025
Q4 		$226K Buy
+1,213
New +$213K ﹤0.01% 270

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Facet Wealth Inc's AZN Position: Q1 2026 in Review

Facet Wealth Inc increased its AstraZeneca (AZN) stake by 17% in Q1 2026, buying an estimated $39.1K and bringing the position to 1,416 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Facet Wealth Inc first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Facet Wealth Inc held 1,416 shares of AstraZeneca worth $279K as of Q1 2026.
  • Facet Wealth Inc bought 203 AstraZeneca shares in Q1 2026, an estimated $39.1K.
  • AstraZeneca made up ﹤0.01% of Facet Wealth Inc's portfolio in Q1 2026, its #272 holding.
  • Facet Wealth Inc first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Facet Wealth Inc's 13F filing for Q1 2026, filed 7 May 2026.